BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35241935)

  • 21. Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected esophageal squamous cell carcinoma.
    Gao Y; Guo W; Cai S; Zhang F; Shao F; Zhang G; Liu T; Tan F; Li N; Xue Q; Gao S; He J
    J Cancer; 2019; 10(14):3188-3196. PubMed ID: 31289589
    [No Abstract]   [Full Text] [Related]  

  • 22. Prognostic value of systemic immune-inflammation index in patients with gastric cancer.
    Wang K; Diao F; Ye Z; Zhang X; Zhai E; Ren H; Li T; Wu H; He Y; Cai S; Chen J
    Chin J Cancer; 2017 Sep; 36(1):75. PubMed ID: 28899420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of systemic immune-inflammation index and platelet-albumin-bilirubin grade in patients with pancreatic cancer undergoing radical surgery.
    Han R; Tian Z; Jiang Y; Guan G; Sun X; Yu Y; Zhang L; Zhou J; Jing X
    Gland Surg; 2022 Mar; 11(3):576-587. PubMed ID: 35402206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High Systemic Immune-Inflammation Index (SII) Represents an Unfavorable Prognostic Factor for Small Cell Lung Cancer Treated with Etoposide and Platinum-Based Chemotherapy.
    Wang C; Jin S; Xu S; Cao S
    Lung; 2020 Apr; 198(2):405-414. PubMed ID: 32016563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Nutritional Index (PNI) in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy as a Useful Prognostic Indicator.
    Chen L; Bai P; Kong X; Huang S; Wang Z; Wang X; Fang Y; Wang J
    Front Cell Dev Biol; 2021; 9():656741. PubMed ID: 33859986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of pre-treatment systemic immune-inflammation index in patients with endometrial cancer.
    Matsubara S; Mabuchi S; Takeda Y; Kawahara N; Kobayashi H
    PLoS One; 2021; 16(5):e0248871. PubMed ID: 33989285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic and recurrent significance of SII in patients with pancreatic head cancer undergoing pancreaticoduodenectomy.
    Chen Q; Ren S; Cui S; Huang J; Wang D; Li B; He Q; Lang R
    Front Oncol; 2023; 13():1122811. PubMed ID: 37284203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive value of the systemic immune-inflammation index for the efficacy of neoadjuvant chemotherapy and prognosis in patients with stage III ovarian cancer-a retrospective cohort study.
    Wang J; Yin S; Chen K
    Gland Surg; 2022 Oct; 11(10):1639-1646. PubMed ID: 36353589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic prediction of systemic immune-inflammation index for patients with gynecological and breast cancers: a meta-analysis.
    Ji Y; Wang H
    World J Surg Oncol; 2020 Aug; 18(1):197. PubMed ID: 32767977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic immune-inflammation index for predicting prognosis of colorectal cancer.
    Chen JH; Zhai ET; Yuan YJ; Wu KM; Xu JB; Peng JJ; Chen CQ; He YL; Cai SR
    World J Gastroenterol; 2017 Sep; 23(34):6261-6272. PubMed ID: 28974892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic changes in the systemic immune-inflammation index predict the prognosis of EGFR-mutant lung adenocarcinoma patients receiving brain metastasis radiotherapy.
    Wang Q; Tan X; Deng G; Fu S; Li J; Li Z
    BMC Pulm Med; 2022 Mar; 22(1):75. PubMed ID: 35241046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pretreatment Systemic Inflammation Response Index in Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy as a Useful Prognostic Indicator.
    Chen L; Kong X; Wang Z; Wang X; Fang Y; Wang J
    Cancer Manag Res; 2020; 12():1543-1567. PubMed ID: 32184659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic immune-inflammation index predicts survival in patients with resected lung invasive mucinous adenocarcinoma.
    Sun W; Zhang P; Ye B; Situ MY; Wang W; Yu Y
    Transl Oncol; 2024 Feb; 40():101865. PubMed ID: 38101174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postoperative Systemic Immune-Inflammation Index (SII): A Superior Prognostic Factor of Endometrial Cancer.
    Huang Y; Chen Y; Zhu Y; Wu Q; Yao C; Xia H; Li C
    Front Surg; 2021; 8():704235. PubMed ID: 34746222
    [No Abstract]   [Full Text] [Related]  

  • 35. Prognostic significance of systemic immune-inflammation index in patients with intrahepatic cholangiocarcinoma undergoing hepatic resection.
    Li H; Wang JJ; Zhang M; Ren B; Li JX; Xu L; Wu H
    World J Gastrointest Oncol; 2020 Apr; 12(4):467-482. PubMed ID: 32368324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Value of the Systemic Immune-Inflammation Index and Prognostic Nutritional Index in Patients With Medulloblastoma Undergoing Surgical Resection.
    Zhu S; Cheng Z; Hu Y; Chen Z; Zhang J; Ke C; Yang Q; Lin F; Chen Y; Wang J
    Front Nutr; 2021; 8():754958. PubMed ID: 34977115
    [No Abstract]   [Full Text] [Related]  

  • 37. Retrospective study of systemic immune-inflammation index in muscle invasive bladder cancer: initial results of single centre.
    Gorgel SN; Akin Y; Koc EM; Kose O; Ozcan S; Yilmaz Y
    Int Urol Nephrol; 2020 Mar; 52(3):469-473. PubMed ID: 31659597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between the systemic immune-inflammation index and the efficacy of neoadjuvant chemotherapy, prognosis in HER2 positive breast cancer-a retrospective cohort study.
    Gu Q; Zhao J; Liu Y; Chen H; Wang L
    Gland Surg; 2023 May; 12(5):609-618. PubMed ID: 37284715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic efficacy of the combination of the pretreatment systemic Immune-Inflammation Index and Epstein-Barr virus DNA status in locally advanced Nasopharyngeal Carcinoma Patients.
    Xiong Y; Shi LL; Zhu LS; Ding Q; Ba L; Peng G
    J Cancer; 2021; 12(8):2275-2284. PubMed ID: 33758605
    [No Abstract]   [Full Text] [Related]  

  • 40. Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Glioblastoma Multiforme Patients Undergoing Postneurosurgical Radiotherapy Plus Concurrent and Adjuvant Temozolomide.
    Topkan E; Besen AA; Ozdemir Y; Kucuk A; Mertsoylu H; Pehlivan B; Selek U
    Mediators Inflamm; 2020; 2020():4392189. PubMed ID: 32565725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.